Page 8 - Andreaf Wainer News Today

Bank of New Hampshire reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 8.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,462 shares of the healthcare product maker’s stock after selling 1,020 shares during the period. Bank of New Hampshire’s […]

Bank of New Hampshire reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 8.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,462 shares of the healthcare product maker’s stock after selling 1,020 shares during the period. Bank of New Hampshire’s […]

Ghe LLC increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,547 shares of the healthcare product maker’s stock after acquiring an additional 182 shares during […]

Lyell Wealth Management LP lessened its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 7.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 55,358 shares of the healthcare product maker’s stock after selling 4,635 shares during the quarter. Lyell Wealth Management […]

Abbott Laboratories (NYSE:ABT – Free Report) had its target price trimmed by Barclays from $141.00 to $140.00 in a research report report published on Monday morning, Benzinga reports. The firm currently has an overweight rating on the healthcare product maker’s stock. A number of other equities analysts have also recently issued reports on ABT. Citigroup […]

Larson Financial Group LLC trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 21.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,640 shares of the healthcare product maker’s stock after selling 449 shares during the period. Larson Financial Group […]

Jennison Associates LLC boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 400,107 shares of the healthcare product maker’s stock after purchasing an additional 4,309 shares during the period. Jennison Associates […]

California Public Employees Retirement System trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,367,706 shares of the healthcare product maker’s stock after selling 44,277 shares during the quarter. […]

Illinois Municipal Retirement Fund grew its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 9.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 186,718 shares of the healthcare product maker’s stock after acquiring an additional 15,598 shares during the period. Illinois Municipal […]

PDS Planning Inc lifted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 113,455 shares of the healthcare product maker’s stock after purchasing an additional 400 shares during the quarter. Abbott Laboratories […]